Central Serous Chorioretinopathy After Scalp And Eyebrow Intralesional Triamcinolone Acetonide Injections: Report Of Two Cases

    July 2024 in “ JAAD Case Reports ”
    Deesha Desai, Ambika Nohria, Lina Alhanshali, Michael Buontempo, Kristen I. Lo Sicco, Craig M. Fern, Jerry Shapiro
    Image of study
    TLDR Corticosteroid injections for hair loss may cause eye problems, so caution is needed.
    This report presents two cases of central serous chorioretinopathy (CSC) following intralesional triamcinolone acetonide (IL-TAC) injections for alopecia areata (AA). A 58-year-old female developed CSC after 4 months of IL-TAC treatment, which improved upon dose reduction. A 34-year-old male developed CSC after receiving IL-TAC injections to the scalp and eyebrows, with symptoms resolving upon discontinuation of IL-TAC. These cases highlight a potential link between IL-TAC injections and CSC, suggesting the need for caution and monitoring when using corticosteroids for localized treatments. Further research is needed to understand the mechanisms and risk factors involved.
    Discuss this study in the Community →

    Cited in this study

    1 / 1 results